UCB SA - ADR (UCBJY)
113.68
-0.54
(-0.47%)
USD |
OTCM |
Oct 08, 16:00
UCB SA - ADR Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 21, 2026 | 46.24B |
| September 18, 2026 | 45.39B |
| September 17, 2026 | 45.45B |
| September 16, 2026 | 44.83B |
| September 15, 2026 | 45.93B |
| September 14, 2026 | 46.10B |
| September 11, 2026 | 45.31B |
| September 10, 2026 | 44.44B |
| September 09, 2026 | 45.05B |
| September 08, 2026 | 45.58B |
| September 04, 2026 | 46.46B |
| September 03, 2026 | 48.82B |
| September 02, 2026 | 48.49B |
| September 01, 2026 | 47.93B |
| August 31, 2026 | 47.45B |
| August 28, 2026 | 47.57B |
| August 27, 2026 | 48.92B |
| August 26, 2026 | 48.79B |
| August 25, 2026 | 49.68B |
| August 24, 2026 | 48.80B |
| August 21, 2026 | 49.07B |
| August 20, 2026 | 47.88B |
| August 19, 2026 | 48.62B |
| August 18, 2026 | 47.84B |
| August 17, 2026 | 47.24B |
| Date | Value |
|---|---|
| August 14, 2026 | 46.55B |
| August 13, 2026 | 47.91B |
| August 12, 2026 | 48.53B |
| August 11, 2026 | 49.54B |
| August 10, 2026 | 49.35B |
| August 07, 2026 | 49.05B |
| August 06, 2026 | 49.11B |
| August 05, 2026 | 50.21B |
| August 04, 2026 | 48.85B |
| August 03, 2026 | 48.38B |
| July 31, 2026 | 48.80B |
| July 30, 2026 | 47.41B |
| July 29, 2026 | 54.28B |
| July 28, 2026 | 54.08B |
| July 27, 2026 | 53.02B |
| July 24, 2026 | 52.80B |
| July 23, 2026 | 52.43B |
| July 22, 2026 | 52.82B |
| July 21, 2026 | 52.86B |
| July 20, 2026 | 51.25B |
| July 17, 2026 | 51.90B |
| July 16, 2026 | 51.45B |
| July 15, 2026 | 51.42B |
| July 14, 2026 | 50.27B |
| July 13, 2026 | 50.93B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 1.147T |
| AstraZeneca PLC | 518.78B |
| Corcept Therapeutics, Inc. | 12.49B |
| Jazz Pharmaceuticals Plc | 16.62B |
| Novo Nordisk A/S | 142.30B |